ProQR Therapeutics PRQR
NASDAQ PRQR
$1.37 -0.01 (-0.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Common Equity (2013 - 2026)

Updated

ProQR Therapeutics' Common Equity came in at $92.38 million for the quarter ended Jun 30, 2026, up 21.8% from $75.82 million a year earlier and up 109.9% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Common Equity (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, ProQR Therapeutics' Common Equity was $55.78 million, down 41.8% from the prior year.

  • Common Equity carries a five-year compound annual growth rate of -2.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Common Equity was $95.85 million in the year ended Dec 31, 2024 (+114.1%), $44.77 million in the year ended Dec 31, 2023 (-36.3%), $70.28 million in the year ended Dec 31, 2022 (-48.0%) and $135.04 million in the year ended Dec 31, 2021 (+109.2%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Common Equity since the quarter ended Dec 31, 2024.
  • Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 47.4%.
  • The fastest year-over-year change in Common Equity over five years came in the quarter ended Sep 30, 2025 (growth of 143.2%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 54.6%).
  • Business Quant data shows PRQR's Common Equity at $44.02 million (quarter ended Mar 31, 2026), $57.47 million (quarter ended Dec 31, 2025) and $66.72 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 84.97 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.94 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 85.49 Bn
10 ProQR Therapeutics 145.89 Mn -314.77 Mn - 90.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.78 Mn
Mar 31, 2026 43.09 Mn
Dec 31, 2025 58.00 Mn
Sep 30, 2025 66.95 Mn
Jun 30, 2025 78.55 Mn
Mar 31, 2025 85.44 Mn
Dec 31, 2024 92.16 Mn
Sep 30, 2024 27.90 Mn
Jun 30, 2024 35.18 Mn
Mar 31, 2024 37.59 Mn
Dec 31, 2023 45.81 Mn
Sep 30, 2023 48.95 Mn
Jun 30, 2023 55.97 Mn
Mar 31, 2023 64.01 Mn
Dec 31, 2022 71.09 Mn
Sep 30, 2022 66.86 Mn
Jun 30, 2022 93.37 Mn
Mar 31, 2022 113.21 Mn
Dec 31, 2021 129.23 Mn
Sep 30, 2021 148.52 Mn
API Access

ProQR Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=PRQR&period=max&api_key=YOUR_API_KEY